Ridgetech vs Exagen
Ridgetech reported revenue of $132 million in fiscal 2026, 2.0 times Exagen's $67 million in fiscal 2025. Ridgetech's revenue grew 10.2% in its latest year, and Exagen's grew 19.6%. Ridgetech had an operating margin of -1.4%, against -21.1% at Exagen. Free cash flow was −$1 million at Ridgetech and −$14 million at Exagen. Their fiscal years end in different months (March 31 and December 31), so the periods don't line up exactly.
Side by side
| Ridgetech | Exagen | |
|---|---|---|
| Latest fiscal year | FY2026, Mar 31, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $132M | $67M |
| Revenue growth | 10.2% | 19.6% |
| Revenue growth a year, last 5 years | −0.1% | 9.7% |
| Gross margin | 3.6% | 58.3% |
| Operating margin | −1.4% | −21.1% |
| Net margin | −0.9% | −30.0% |
| Free cash flow | −$1M | −$14M |
| Free cash flow margin | −1.1% | −21.4% |
| Return on capital | — | −115.0% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 96.6% | 18.4% |
| Last close | $1.02 | $3.80 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $161,242, sold $115,597 | sold $252,640 |
| Piotroski F-score | — | 3 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
RidgetechExagen
Operating margin
Percent of revenue
RidgetechExagen
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
RidgetechExagen